Ocular Therapeutix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	63.72	58.44	51.49	43.52	17.4	Upgrade
Revenue Growth (YoY)	9.03%	13.49%	18.32%	150.08%	311.71%	Upgrade
Cost of Revenue	133.26	66.34	58	54.49	30.78	Upgrade
Gross Profit	-69.54	-7.89	-6.51	-10.97	-13.37	Upgrade
Selling, General & Admin	103.84	74.49	72.15	67.07	49.47	Upgrade
Operating Expenses	103.84	74.49	72.15	67.07	49.47	Upgrade
Operating Income	-173.38	-82.38	-78.65	-78.04	-62.85	Upgrade
Interest Expense	-13.58	-11.34	-7.02	-6.67	-6.77	Upgrade
Interest & Investment Income	20.28	3.98	0.8	0.03	0.17	Upgrade
Other Non Operating Income (Expenses)	-0.48	-5.19	13.84	78.12	-86.19	Upgrade
EBT Excluding Unusual Items	-167.16	-94.93	-71.04	-6.55	-155.64	Upgrade
Merger & Restructuring Charges	1.6	-	-	-	-	Upgrade
Other Unusual Items	-27.95	14.19	-	-	-	Upgrade
Pretax Income	-193.51	-80.74	-71.04	-6.55	-155.64	Upgrade
Net Income	-193.51	-80.74	-71.04	-6.55	-155.64	Upgrade
Net Income to Common	-193.51	-80.74	-71.04	-6.55	-155.64	Upgrade
Shares Outstanding (Basic)	158	80	77	76	61	Upgrade
Shares Outstanding (Diluted)	158	86	83	82	61	Upgrade
Shares Change (YoY)	84.90%	3.57%	0.59%	35.24%	34.19%	Upgrade
EPS (Basic)	-1.22	-1.01	-0.92	-0.09	-2.56	Upgrade
EPS (Diluted)	-1.22	-1.02	-0.97	-0.98	-2.56	Upgrade
Free Cash Flow	-135.97	-76.32	-63.32	-66.74	-54.4	Upgrade
Free Cash Flow Per Share	-0.86	-0.89	-0.77	-0.81	-0.90	Upgrade
Gross Margin	-109.13%	-13.51%	-12.64%	-25.20%	-76.85%	Upgrade
Operating Margin	-272.08%	-140.96%	-152.74%	-179.31%	-361.13%	Upgrade
Profit Margin	-303.67%	-138.15%	-137.95%	-15.06%	-894.31%	Upgrade
Free Cash Flow Margin	-213.37%	-130.59%	-122.96%	-153.36%	-312.56%	Upgrade
EBITDA	-169.6	-79.4	-76.55	-75.62	-60.07	Upgrade
EBITDA Margin	-266.14%	-135.86%	-148.65%	-173.74%	-	Upgrade
D&A For EBITDA	3.79	2.98	2.11	2.42	2.77	Upgrade
EBIT	-173.38	-82.38	-78.65	-78.04	-62.85	Upgrade
EBIT Margin	-272.08%	-140.96%	-152.74%	-179.31%	-	Upgrade
Revenue as Reported	63.72	58.44	51.49	43.52	17.4	Upgrade

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q